The bactericidal activity of gatifloxacin in plasma and urine [1]  by Naber, K.G.
CORRESPONDENCE 
The bactericidal activity of gatifloxacin in 
plasma and urine [l] 
Clin Microbiol Infect 1998; 4: 731 
Suitable pharmacodynamic parameters which predict 
successful clinical outcome could optimize the design 
of clinical studies. Serum and urinary bactericidal titers 
may be supportive in this respect, if these parameters 
reflect the in vivo situation of a specific infectious status 
as closely as possible. 
When performing such studies, special care has to 
be taken in choosing the right media for diluting the 
body fluids (plasma or urine). The NCCLS method [2] 
applied by the authors to determine the serum 
bactericidal activity does not recommend any specific 
media, and Mueller-Hinton broth (MHB) was used in 
their study to dilute the plasma samples. After several 
dilution steps there is almost no serum present. The 
results achieved can therefore be predicted from the 
serum concentration of the active drug and the minimal 
bactericidal concentration (MBC) of a pathogen 
determined in vitro in MHB. Since the influence of the 
specific biological medium is no longer included, such 
parameters do not add new information above the 
routine pharmacokinetic results and the in vitro 
antibacterial activity of an investigated drug. 
For the evaluation of new compounds in the treat- 
ment of urinary tract infections, we used as a urine 
bactericidal test a modification of various methods 
published [3]. Very early, we recognized that the proper 
medium for diluting the urine samples was urine and 
not any other synthetic medium (such as MHB), 
because we could demonstrate that the urinary 
bactericidal titers (UBTs) determined with urine as 
diluent were three to two dilution steps lower than 
those with MHB as diluent [4]. In a lengthy personal 
communication during a meeting with the sponsors for 
developing gratifloxacin, we brought the principal 
author’s attention to this finding and supplied him with 
our past publications describing the method we 
developed. 
The authors [l] used urine as diluent but standard- 
ized the pH to 6, which may lead to more reproducible 
results but again does not reflect the biological variation 
we have to face. Therefore, in our studies we used the 
specific subject’s individual antibiotic-free urine as 
diluent [4-61. Taking this into consideration, the range 
of results may become wider but better reflects the 
biological reality. For clinical purposes, the lowest titers 
and not the median ones should determine the dose 
necessary for treatment to include also those patients 
with relatively low bactericidal activity. 
Since the method of UBT is not standardized yet, 
comparisons of results are only allowed between studies 
using exactly the same method. The relevance of the 
absolute titers concerning outcome is also not estab- 
lished. Therefore, UBTs can only be considered as a 
relative comparison between alternative drugs or 
regimens. In clinical studies the predictive value of 
UBTs should be evaluated. 
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Reading Haemophilus influenzae Etest macrolide and 
amoxycillin susceptibilities: inter-observer variation 
appears to be small 
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Tande et al. [l] and others [2] reported on significant 
inter-laboratory variations when using the Etest (AB 
Biodisk, Solna, Sweden) to judge the susceptibility of 
common respiratory pathogens to various antibiotics. 
This test is now used widely both for special studies 
and, increasingly, for routine diagnostic bacteriology 
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